We are delighted to be holding our next Clinical Trials Special Interest Group series, organised in partnership with Afortiori Development. This online event will bring together a panel of experts to answer your questions relating to Validating Digital Health: From Artificial Intelligence to Clinical Evidence.
Rather than formal presentations, this hour-long session will take a roundtable discussion / Q&A format.
Our panel brings together specialists from our partners at Afortiori, alongside guest speakers from other industry leaders.
Joining us on the day will be:
- Dr Nicola Wall, Afortiori Development
- Prof Peter Bannister – Entrepreneur and Expert technology specialist
- Dr Lauris Kemp – IP Expert
- Timothy Bubb – Regulatory Expert
Full speaker biographies can be found below.
This free-to-attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses, the value of which is £127, but is delivered completely free of charge to participants.
Please note: whilst this event is held as part of the SoLSTICE programme, attendance is not restricted to companies in the Leicester/Leicestershire area and is open to all.
DURATION: 1 hour
Speaker Profiles:
Chaired by: Dr Nicola Wall, Chief Executive Officer, Afortiori Development
Nicola co-founded Afortiori Development after a long career in clinical research within a variety of roles. Nicola has extensive experience and a proven track record in global clinical trial management, quality assurance and process management in the healthcare industry. Afortiori have built an impressive global team of clinical trial specialists, clinicians and biostatisticians with experience in adult, paediatric and neonatal clinical research, and both primary and secondary healthcare settings.
Peter Bannister, Managing Director, Romilly Life Sciences Ltd
Peter has helped build multiple high-growth biomedical businesses, commercialising innovative products for surgery, diagnostics and digital treatment pathways across international markets and leading R&D, regulated product development and strategic business development. He founded Romilly Life Sciences to help cross-sector teams from health, tech and pharma organisations implement, evidence and scale solutions based on data and artificial intelligence (AI). He is also co-founder of Migration Biotherapeutics, Honorary Professor at the University of Birmingham Centre for Regulatory Science and Innovation, Fellow and Chair of Healthcare at the Institution of Engineering and Technology, an Academy of Medical Sciences Future Leader in Innovation Enterprise and Research (FLIER) and serves as NIHR Industry Spokesperson on AI.
Dr Lauris Kemp, Partner, HGF Ltd
Lauris is a UK and European patent attorney and a partner in HGF’s biotech team. She has a strong life sciences background with a first degree in Immunology and Biochemistry; and a PhD and 6 years post-doctoral experience covering cell expression systems, protein purification, mass spectrometry, protein crystallography and bioinformatics. Her patent work reflects this broad base and Lauris handles increasing numbers of bioinformatics applications, securing commercially useful claims for clients. She has drafted and prosecuted bioinformatics applications in metagenomic and microbiome sequencing, in silico drug testing and AI cancer diagnostics. She has also successfully defended bioinformatics patents at EPO opposition proceedings.
Timothy Bubb, Technical Director, IMed Consultancy Ltd
With more than ten years’ experience in QA/RA roles, Tim has breadth and depth of knowledge across the regulatory, engineering, clinical, design and development, and quality assurance disciplines. Tim has a passion for empowering innovation in medical devices and brings insight and pragmatism to projects bringing complex lifesaving and life enhancing products to market.